Market News

State Of New Jersey Common Pension Fund D Raised Its Alexion Pharmaceuticals (ALXN) Position; Stella-Jones Inc. (TSE:SJ) Had 1 Bullish Analysts

Among 6 analysts covering Stella-Jones Inc (TSE:SJ), 1 have Buy rating, 0 Sell and 5 Hold. Therefore 17% are positive. Stella-Jones Inc had 37 analyst reports since August 10, 2015 according to SRatingsIntel. TD Securities maintained it with “Hold” rating and $43 target in Thursday, April 13 report. RBC Capital Markets downgraded the stock to “Sector Perform” rating in Monday, January 16 report. The company was upgraded on Monday, September 19 by Desjardins Securities. The firm has “Sector Perform” rating by Scotia Capital given on Friday, August 12. RBC Capital Markets maintained Stella-Jones Inc. (TSE:SJ) on Tuesday, October 17 with “Outperform” rating. The stock has “Sector Perform” rating by RBC Capital Markets on Monday, April 3. The company was maintained on Wednesday, November 9 by Scotia Capital. RBC Capital Markets maintained Stella-Jones Inc. (TSE:SJ) on Tuesday, May 2 with “Sector Perform” rating. RBC Capital Markets maintained it with “Outperform” rating and $56 target in Wednesday, July 20 report. On Monday, August 10 the stock rating was maintained by Desjardins Securities with “Hold”. See Stella-Jones Inc. (TSE:SJ) latest ratings:

17/11/2017 Broker: TD Securities Rating: Hold Old Target: $48.00 New Target: $49.00 Target Up
17/10/2017 Broker: National Bank Canada Rating: Sector Perform Old Target: $48.00 New Target: $52.00 Target Up
17/10/2017 Broker: RBC Capital Markets Rating: Outperform New Target: $56.00 Maintain

State Of New Jersey Common Pension Fund D increased Alexion Pharmaceuticals Inc (ALXN) stake by 30.56% reported in 2017Q3 SEC filing. State Of New Jersey Common Pension Fund D acquired 55,000 shares as Alexion Pharmaceuticals Inc (ALXN)’s stock declined 11.63%. The State Of New Jersey Common Pension Fund D holds 235,000 shares with $32.97M value, up from 180,000 last quarter. Alexion Pharmaceuticals Inc now has $25.96B valuation. The stock decreased 1.47% or $1.75 during the last trading session, reaching $117.1. About 1.56 million shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 18.12% since February 22, 2017 and is downtrending. It has underperformed by 34.82% the S&P500.

Among 29 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 24 have Buy rating, 0 Sell and 5 Hold. Therefore 83% are positive. Alexion Pharmaceuticals Inc. had 100 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has “Outperform” rating given on Friday, February 9 by Leerink Swann. Stifel Nicolaus maintained the shares of ALXN in report on Friday, December 11 with “Buy” rating. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) earned “Buy” rating by Stifel Nicolaus on Tuesday, September 12. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has “Buy” rating given on Wednesday, December 6 by Leerink Swann. The stock has “Buy” rating by Citigroup on Friday, February 9. Wedbush initiated it with “Neutral” rating and $132 target in Friday, September 23 report. The firm has “Buy” rating given on Thursday, February 8 by Piper Jaffray. The company was maintained on Thursday, February 8 by Stifel Nicolaus. On Friday, October 28 the stock rating was upgraded by FBR Capital to “Mkt Perform”. The firm earned “Buy” rating on Friday, July 29 by Stifel Nicolaus.

State Of New Jersey Common Pension Fund D decreased Cogent Communications Hldgs (NASDAQ:CCOI) stake by 100,000 shares to 300,000 valued at $14.67 million in 2017Q3. It also reduced Boston Beer Inc (NYSE:SAM) stake by 6,500 shares and now owns 20,000 shares. Ligand Pharmaceuticals Inc (NASDAQ:LGND) was reduced too.

Since August 28, 2017, it had 0 insider buys, and 14 insider sales for $6.68 million activity. The insider HANTSON LUDWIG sold 13,245 shares worth $1.54 million. Veneman Ann M had sold 835 shares worth $121,751. Another trade for 1,651 shares valued at $192,028 was made by Goff Brian on Tuesday, February 6. $16,800 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was sold by Wagner Heidi L. $636,285 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was sold by O’Neill Julie. Franchini Indrani Lall sold $169,696 worth of stock. $389,099 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was sold by Moriarty John B on Tuesday, February 6.

Investors sentiment decreased to 1.17 in 2017 Q3. Its down 0.20, from 1.37 in 2017Q2. It dived, as 36 investors sold ALXN shares while 174 reduced holdings. 78 funds opened positions while 167 raised stakes. 206.89 million shares or 0.54% less from 208.01 million shares in 2017Q2 were reported. Raymond James Svcs Inc stated it has 30,544 shares. Td Asset Management invested 0.09% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Tobam reported 1.94% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Hudson Bay Capital Management LP holds 0.14% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 40,000 shares. Reliance Trust Of Delaware invested in 5,265 shares or 0.11% of the stock. 944,006 were reported by Aqr Capital Management Lc. Korea Investment reported 107,073 shares. Balyasny Asset Mngmt Ltd Llc holds 172,944 shares or 0.1% of its portfolio. Victory Capital Inc reported 0.04% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Odey Asset Management Grp Limited stated it has 20,277 shares. Envestnet Asset holds 13,587 shares. Zeke Advsr Limited Co owns 3,751 shares or 0.07% of their US portfolio. Pictet Cie (Europe) Sa accumulated 0.14% or 6,730 shares. Moreover, Ibm Retirement Fund has 0.15% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 5,325 shares. Alliancebernstein Limited Partnership, New York-based fund reported 515,592 shares.

The stock decreased 0.02% or $0.01 during the last trading session, reaching $47.99. About 140,800 shares traded or 48.95% up from the average. Stella-Jones Inc. (TSE:SJ) has 0.00% since February 22, 2017 and is . It has underperformed by 16.70% the S&P500.

Leave a Reply

Your email address will not be published. Required fields are marked *